Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with high androgen levels may have more severe COVID-19 symptoms.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride may cause cataracts and floppy-iris syndrome.

Suppressing certain hormones might help prevent prostate cancer.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Male hormones worsen kidney transplant damage, but blocking them helps.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

A woman with severe angioedema improved significantly after treatment with rituximab.